A multi-targeted approach to treating bone metastases
Daniel F Camacho1, Kenneth J Pienta
1Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, 7431 CCC 1500 E Medical Ctr, Ann Arbor, MI, 48109, USA.
Abstract:
The treatment of bone-metastatic cancer now takes advantage of the unique biology of this clinical state. The complex interplay between the cancer cells and the bone microenvironment leads to a host of therapeutic targets, with agents in various stages of clinical use or study. Targets include interactions between the cancer cells and osteoclasts, osteoblasts, endothelial cells, stromal cells, hematopoietic progenitor cells, cells of the immune system, and the bone matrix. Efforts at understanding specific mechanisms of drug resistance in the bone are also ongoing. Successful clinical outcomes will be the result of co-targeting and interrupting the various tumor-supportive elements and cooperating pathways at the level of the tumor cell, the primary and metastatic microenvironments, and systemic cancer effects, leading to a "scaled network disruption" to undermine the disease state.
Insights
Treating bone metastasis involves targeting cancer cell interactions within the bone microenvironment. A "scaled network disruption" approach is key for successful outcomes in bone cancer treatment.
Area of Science:
- Oncology
- Bone Biology
- Cancer Therapeutics
Background:
- Bone metastasis presents unique biological challenges and therapeutic opportunities.
- The bone microenvironment comprises various cells and matrix components that interact with cancer cells.
- Understanding these interactions is crucial for developing effective treatments.
Purpose of the Study:
- To review the therapeutic targets arising from the interplay between cancer cells and the bone microenvironment.
- To discuss ongoing efforts in understanding drug resistance mechanisms in bone metastasis.
- To propose a comprehensive strategy for treating bone-metastatic cancer.
Main Methods:
- Review of current literature on bone metastasis and therapeutic targets.
- Analysis of cellular and molecular interactions within the bone microenvironment.
- Synthesis of information on drug resistance mechanisms and co-targeting strategies.
Main Results:
- Identified numerous therapeutic targets, including cancer cell interactions with osteoclasts, osteoblasts, endothelial cells, stromal cells, hematopoietic progenitor cells, immune cells, and the bone matrix.
- Highlighted ongoing research into specific drug resistance mechanisms in the bone.
- Emphasized the need for a multi-faceted approach to treatment.
Conclusions:
- Effective treatment of bone metastasis requires co-targeting multiple tumor-supportive elements and pathways.
- A "scaled network disruption" strategy, targeting tumor cells, microenvironments, and systemic effects, is proposed.
- This comprehensive approach aims to undermine the disease state for improved clinical outcomes.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...